Hims & Hers advances global digital health footprint with Eucalyptus acquisition

Hims & Hers Health, Inc. has finalized its acquisition of digital healthcare provider Eucalyptus. The transaction expands the company's operational reach across four continents, supporting its long-term strategy to scale personalized consumer health solutions and achieve its 2030 financial targets.

Hims & Hers Health, Inc., a US-based telehealth platform that connects consumers with licensed healthcare professionals, has finalized its acquisition of digital health platform Eucalyptus, according to official company disclosures.

The transaction integrates the target company's clinical framework and a user base of over 850,000 clients into the parent organization's existing portfolio.

This cross-border consolidation secures a broader market presence for the combined entity across North America, Europe, and the Asia-Pacific region. By expanding its data ecosystem and footprint to four continents, the platform aims to drive global network effects, bringing it closer to its projected 2030 financial targets of $6.5 billion in revenue and $1.3 billion in adjusted EBITDA.

The expansion signals a tightening competitive landscape within the digital health sector. Telehealth providers are increasingly leveraging international mergers and acquisitions to bypass regional regulatory hurdles and establish localized clinical infrastructure. This consolidation allows platforms to standardize quality assurance while tailoring medical offerings to distinct regulatory environments.

For institutional investors and pharmaceutical innovators, this scale establishes the platform as a significant distribution channel for customized therapeutic treatments. Furthermore, the integration of extensive patient data points strengthens the enterprise's ability to optimize long-term consumer retention and health outcomes, altering how digital care delivery is scaled globally.